Heart Disease Trial, Recruiting NCT06623344 Sponsor: Johns Hopkins University Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06623344
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your heart's pumping function (called ejection fraction) is below 50%, meaning your heart is not pumping as efficiently as normal
  • You are willing to give your agreement to participate (informed consent)
  • You do not feel extreme discomfort in small, enclosed spaces (claustrophobia)
  • You are 21 years of age or older
  • You are able to walk and move around (you do not need to be a hospital inpatient)

Who may not be able to join:

  • You have a known allergy to a type of dye called gadolinium, which is used in MRI scans
  • You have metal fragments in your eyes, brain, or spinal cord
  • Your kidneys are not filtering blood well enough — specifically, your kidney filtration rate (GFR) is at or below 45 mL/min (confirm with trial site)
  • You are pregnant
  • You have an internal electrical device in your body, such as a hearing implant (cochlear implant), spinal cord stimulator, pacemaker, or defibrillator
  • You have any other medical history or condition that the trial doctor feels could cause problems (confirm with trial site)
  • You have severe fear of enclosed spaces (severe claustrophobia)
  • You weigh more than 300 lbs (136 kg), due to weight limits on the MRI scanning table

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joao AC Lima, MD, Johns Hopkins University

Phone: 410-614-1284

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 November 2024
Est. completion
1 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Subcortical Volumes in Heart Failure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov